D.9. Key Learning Outcomes

1. Has knowledge in the area of preformulation and formulation designs about industrial production, quality control, quality assurance system and stability

2. Acquires information about nanotechnology, new drug delivery systems and controlled release systems

3. Learns to keep track of up to date literature and patents using the knowledge and informatics technologies

4. Interprets the guidelines of health authorities such as FDA, EMA and international guidelines such as GMP, ANDA, BA/BE, QA/QC, acquires application knowledge and skills

5. Has knowledge to understand and interpret chemical, instrumental and pharmacological data

6. Has basic concepts about medicinal chemistry such as design of new drug molecules, drug-receptor interactions

7. Has the knowledge on the rules of scientific ethics which should be complied

8. Effectively uses the conventional and new synthetic methods.

9. Has knowledge of advanced toxicity tests accepted by regulatory authorities

10. Has knowledge about pharmacological experimental methods and their applications used in drug research and evaluates analysis results

11. Has knowledge about preclinical and clinical drug research

12. Has knowledge about the pharmacokinetic and pharmacodynamic properties of drugs

13. Has knowledge about the pharmacokinetics and pharmacodynamics of drugs

14. Has knowledge of and the ability to use the devices and instruments used in the application of instrumental analysis methods

15. Has the ability to apply theoretical and practical knowledge in the analysis of substances in medicinal products and biological materials